Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sanofi
Sanofi
Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD
Fierce Pharma
Thu, 03/23/23 - 11:44 am
Sanofi
Regeneron
Dupixent
COPD
clinical trials
AAD: Will Sanofi and Regeneron’s Dupixent be a game-changer or just another antibody on the COPD scrapheap?
Fierce Pharma
Mon, 03/20/23 - 10:06 am
Sanofi
Regeneron
Dupixent
COPD
Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs
Endpoints
Thu, 03/16/23 - 09:16 pm
Sanofi
Lantus
insulin
diabetes
drug pricing
Eli Lilly
Novo Nordisk
Sanofi throws down $2.9B to acquire diabetes partner Provention Bio
Fierce Pharma
Mon, 03/13/23 - 10:08 am
Sanofi
Provention Bio
M&A
diabetes
Sanders urges Sanofi, Novo Nordisk to be like Eli Lilly in reducing insulin prices
Fierce Pharma
Sun, 03/5/23 - 03:26 pm
Eli Lilly
Novo Nordisk
Sanofi
insulin
Bernie Sanders
drug pricing
Sanofi’s clinical trial of hemophilia A therapy in children meets endpoint
Clinical Trials Arena
Sun, 03/5/23 - 03:12 pm
Sanofi
clinical trials
hemophilia A
Altuviiio
FDA Approves Regeneron-Sanofi's Sarilumab As First Biologic For Stiffness, Pain In Muscles
Yahoo/Benzinga
Wed, 03/1/23 - 07:07 pm
Regeneron
Sanofi
FDA
Kevzara
Sarilumab
polymyalgia rheumatica
Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market
Fierce Biotech
Tue, 02/28/23 - 10:03 am
Junshi Biosciences
Amgen
Sanofi
China
clinical trials
PCSK9 inhibitors
FDA approves Sanofi’s long-lasting hemophilia drug
BioPharma Dive
Thu, 02/23/23 - 04:32 pm
Sanofi
FDA
hemophilia A
Altuviiio
Pfizer's maternal RSV vaccine filing gets priority review, setting up showdown with AstraZeneca, Sanofi
Fierce Pharma
Tue, 02/21/23 - 10:26 am
Pfizer
RSV
vaccines
GSK
AstraZeneca
Sanofi
RSVpreF
First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness
Forbes
Mon, 02/20/23 - 12:37 pm
RSV
vaccines
GSK
Pfizer
Sanofi
Sobi
Moderna Therapeutics
AstraZeneca
JNJ
FDA
Sanofi and Regeneron face a high-risk test for Dupixent
EP Vantage
Fri, 02/17/23 - 10:20 am
Sanofi
Regeneron
Dupixent
COPD
clinical trials
US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case
Endpoints
Mon, 02/13/23 - 10:12 pm
Pfizer
Viatris
Sanofi
Regeneron
patents
Supreme Court
Reed relinquishes R&D reins at Sanofi to pursue new opportunity, sparking race to find successor
Fierce Biotech
Mon, 02/13/23 - 10:36 am
R&D
Sanofi
John Reed
Dupixent kicks off 2023 as top pharma brand for ad impressions
Medical Devices and Diagnostics Industry
Mon, 02/6/23 - 06:13 pm
Sanofi
Dupixent
asthma
pharma advertising
Vaccines slip, Dupixent climbs for Sanofi as it readies multiple launches in 2023
Fierce Pharma
Mon, 02/6/23 - 10:58 am
Sanofi
Dupixent
earnings
Sanofi Admits Defeat for Myasthenia Gravis Candidate, Drops Phase III Trial
BioSpace
Fri, 02/3/23 - 10:31 am
Sanofi
tolebrutinib
myasthenia gravis
New competitors push Sanofi to offer voluntary retirement packages at two Indian sites
Endpoints
Tue, 01/31/23 - 11:20 pm
Sanofi
India
drug manufacturing
AstraZeneca, Novo Nordisk and Sanofi score 340B-related appeals court win over HHS
Endpoints
Mon, 01/30/23 - 05:58 pm
AstraZeneca
Sanofi
Novo Nordisk
340B
drug discounts
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
television ads
pharma marketing
DTC ads
AbbVie
Rinvoq
Dupixent
Sanofi
Regeneron
Skyrizi
Novo Nordisk
Ozempic
Jardiance
Eli Lilly
Boehringer Ingelheim
Rybelsus
Trulicity
Rexulti
Otsuka
Lundbeck
Tremfya
JNJ
Verzenio
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »